BlackRock »

Xilio Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $60k 76k 0.79

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Rock Springs Capital Management
RiverVest Venture Management
Morgan Stanley
Vanguard Group
Geode Capital Management
Balyasny Asset Management
Renaissance Technologies
BlackRock
Bridgeway Capital Management
BlackRock
State Street Corporation
SevenBridge Financial
Northern Trust
Raymond James & Associates

View all funds holding Xilio Therapeutics